Market closed

STERIS /$STE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About STERIS

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Ticker

$STE
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies
Headquarters
Mentor, United States

Employees

18,000
Website
www.steris.com

STERIS Metrics

BasicAdvanced
$20B
47.41
$4.37
0.85
$2.18
1.10%

$20B

0.85

$245.06

$197.82

495K

$2.18

2.406

1.36

34.632

36.303

48.40%

7.50%

5.54%

9.27%

47.413

3.847

3.1

44.93

30.124

1.05%

1.10%

13.19%

-20.50%

11.44%

16.72%

9.33%

What the Analysts think about STERIS

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for STERIS stock.

STERIS Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

STERIS Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

STERIS News

AllArticlesVideos
Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Seeking Alpha·2 months ago
Steris beats quarterly estimates on continued demand for medical procedures

Steris beats quarterly estimates on continued demand for medical procedures

Reuters·2 months ago
STERIS Announces Financial Results for Fiscal 2025 Second Quarter

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $STE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for STERIS stock?

STERIS (STE) has a market cap of $20B as of January 15, 2025.

What is the P/E ratio for STERIS stock?

The price to earnings (P/E) ratio for STERIS (STE) stock is 47.41 as of January 15, 2025.

Does STERIS stock pay dividends?

Yes, the STERIS (STE) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $2.18 and the yield is 1.1%. STERIS has a payout ratio of 48.4% on a trailing twelve-month basis.

When is the next STERIS dividend payment date?

The next STERIS (STE) dividend payment date is unconfirmed.

What is the beta indicator for STERIS ?

STERIS (STE) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.